Abstract This study aimed to quantify the amount of change in Standardised Uptake Values (SUVs) of PET/CT images by simulating the set-up as closely as possible to the actual patient scanning. The experiments were conducted using an anthropomorphic phantom, which contained an amount of radioactivity in the form of Fluorodeoxyglucose (FDG) in a primary plastic test tube and one litre saline bags, including the insertion of bony structures and another two test tubes containing different concentrations of iodine contrast media. Standard scanning protocols were employed for the PET/CT image acquisition. The highest absolute differences in the SUVmax and SUVmean values of the saline bags were found to be about 0.2 and 0.4, respectively. The primary test tube showed the largest change of 1.5 in both SUVs; SUV max and SUVmean. However, none of these changes were found to be statistically significant. The clinical literature also contains no evidence to suggest that the changes of this magnitude would change the final diagnosis. Based on these preliminary data, we propose that iodine contrast media can be used during the CT scan of PET/CT imaging, without significantly affecting the diagnostic quality of this integrated imaging modality.
Introduction
An integrated Positron Emission Tomography/Computed Tomography (PET/CT) has been commercially available in the clinical setting since 2001 [1] . A PET/CT imaging modality provides several benefits as compared to a dedicated PET machine. It allows acquisition of functional PET and anatomical CT scans in a single imaging session on the same modality [2] . These two sets of images are intrinsically co-registered and thus more accurate anatomical localisation of the PET tracer uptake can be achieved [3] . In PET/CT imaging, the CT dataset can be used to derive the information required for the attenuation correction of the PET emission data [2] . Kinahan et al. [4] have reported on the potential advantages of using a CT dataset in calculating the gamma ray attenuation correction factor for the PET component of the scan. The conversion of CT data into the PET attenuation correction factor employs a simple bilinear transform method [2, 4, 5] , however this method is only well established for non-contrast CT scans [2, 4, 5] . The CT image acquisition for the PET/CT imaging is commonly performed without iodine contrast media [6] . Therefore, it is of interest to determine whether the application of iodine contrast media during the CT scan will affect the PET data.
Non-ionic iodine contrast media is used to enhance the blood vessels and delineate the bowels in contrastenhanced CT (CECT) scans [7] . This will increase the sensitivity and accuracy in the detection and characterisation of the lesions [8, 9] , and at the same time improve the CT image contrast [10] . On the other hand, due to the combination of a very high attenuation value (expressed in Hounsfield Units; HU) per unit density of iodine with its modest concentrations in tissue, the HU values of contrast enhanced soft tissues and bone can overlap or be identical in CECT images [5] . Therefore, when a CECT dataset is used for correcting the attenuation data of PET, the standard bilinear conversion algorithm; which is exclusively based on HU, cannot distinguish between both of these tissues [5] . This will lead to an overestimate on the attenuation correction factor of PET data [11] [12] [13] , because the attenuation value of iodine falls off more rapidly with increasing energy (mostly caused by the photoelectric effect) than any other tissues [14] . Additionally, the clearance of an intravenous contrast media between the CT image acquisition and the PET scan could result into this attenuation artifact [15] . However, the subsequent effect of this image artifact on the PET SUV values may not be of consequence, as several studies have found that the changes are clinically insignificant [5, 14, 16, 17] . Thus, the application of contrast media in PET/CT imaging is no longer a matter of debate [18] . Indeed, three distinct methods have been proposed for addressing and resolving this issue, which can be summarised as follows: (a) adjustments of the attenuation correction method [4, 10, 12] , (b) implementation of modifications on acquisition protocols [21] [22] [23] and (c) application of dual energy CT scans [13] .
In this study, we attempted to determine if any correction was required by measuring the change in the SUVs caused by iodine contrast media using a phantom designed to simulate as closely as possible the actual patient scan conditions. Our phantom was specifically designed to simulate the case of a spinal metastasis at the lower abdomen level. The phantom allowed insertion of three dried human spinal vertebrae to simulate the spine and a tube of 18 F solution could be positioned in the foramen to simulate a spinal metastasis. To the best of our knowledge, no phantom study to determine the effects of non-ionic iodine contrast media on the SUVs in this clinically important geometry has been reported. The aim of this study was to address a gap in the literature by quantifying the effects of iodine contrast media on the SUVs of the PET/CT images in the above condition.
Materials and methods

Scanning protocols
A Philips Gemini Dual PET/CT system was used for image acquisition. This hybrid system is essentially a coupling of the Allegro 3D PET scanner with gadolinium oxyorthosilicate (GSO) crystal detectors to the Mx8000 EXP DualSlice CT imaging system. This integrated modality has the capability to image a patient using both scanners in a single imaging session without moving the patient from the couch. The image acquisition starts with a low-dose CT scan (140 kVp, 30 mAs, slice thickness of 5 mm, pitch factor of 1.0 and gantry rotation speed of 1.0 s) which then enables a following PET emission scan. The PET emission scan parameters were: 3D acquisition mode; slice image matrix of 144 9 144 pixels, axial Field of View (FOV) 18 cm, acquisition time 3 min per FOV, and slice thickness 4 mm with 5 mm reconstruction thickness to match the CT images.
Phantom study
All imaging scans were conducted using an anthropomorphic phantom, comprising an ovoid plexiglass cylinder with such size and thickness as to replicate a standard man's chest wall. The phantom study has four different phases.
Phase 1: identification of the Hounsfield units
There are three main reasons for choosing liver as our organ of interest: (a) it is the second largest organ in human body, (b) it shows an elevation in CT numbers (HU) on CECT images, and (c) there is a moderate physiological uptake of FDG in the normal liver on PET images. The uptake of iodine contrast media in the liver is dependent upon the delay from injection to scanning, but the optimum HU for the normal liver due to contrast uptake in a CECT scan should be more than 100, based on our clinical experience and the data published by Halls [19] . A one litre normal saline bag was used to simulate the normal liver (we labelled it as saline bag 2; as it was used in all four phases). Prior to the PET/CT scanning procedure, iodine contrast media (Omnipaque 300 mgI/ml, GE Healthcare) was injected into saline bag 2 (at 5 ml intervals). The CT scans were performed until saline bag 2 had the average maximum HU (HUmax) of greater than 100, as to simulate the HU values of a normal contrast-enhanced liver. For stabilisation purposes, four extra saline bags were inserted into the phantom along with saline bag 2, as depicted in Fig. 1 . The CT images were analysed by the CT operator using the standard clinical interface tools.
To eliminate the possibility of machine dependent artefacts influencing the results, the CT scans were conducted using the PET/CT system. These CT scans were also repeated three times to establish reproducibility of the results. In this phase, a simulation of bony structures was introduced into the anthropomorphic phantom; for this purpose we used three dried human spinal vertebrae. One test tube (designated tube 1) of volume 10 ml and inner diameter 1 cm containing FDG (1.3 MBq) was inserted into the vertebral foramen of the vertebrae (Fig. 3) . Saline bags 1 and 2 were re-used for this phase, 14 days after phase 2.
For this phase both bags were injected with 9.5 MBq radioactivity of FDG. To minimise the impact of minor variations in phantom geometry on the results, PET/CT imaging was repeated four times, with the following parameters (refer Table 1 ): (a) PET/CT3a imaging of Fig. 1 The set-up for the anthropomorphic phantom, which has been filled with saline bag 2 and four additional saline bags. The black thick arrow shows saline bag 2 which has been injected with 15 ml of iodine contrast media so that the CT number of the bag is over 100 HU, simulating normal liver contrast enhancement Fig. 2 The imaging set-up for phase 2 of the phantom study. The phantom is first imaged with saline bag 1 in place to obtain PET/CT2a (saline bag 1 contains radioactivity of FDG but no contrast). The phantom is then re-imaged with saline bag 2 replacing saline bag 1 to obtain PET/CT2b (saline bag 2 contains the same radioactivity of FDG as in saline bag 1, but also contains the typical clinically observed contrast uptake for the liver) In the lower abdomen region, the closest structures to the vertebral columns which are expected to show CECT enhancement are the abdominal aorta and inferior vena cava. To simulate this we introduced another two test tubes (designated tube 2 and 3), containing different iodine concentrations (Omnipaque 300 mgI/ml); tube 3 having a higher concentration than tube 2 (19.0 mg/ml vs. 6.0 mg/ ml). The modular components of the plexiglass phantom for phase 4 were then: saline bag 1 with no iodine contrast and 9.3 MBq of FDG injected; saline bag 2 with sufficient iodine contrast to increase its CT number by 100 HU and also with 9.3 MBq of FDG injected; tube 1 with 1.7 MBq of FDG injected; tube 2 with iodine contrast, stuck to the side of the vertebrae when deployed; and tube 3 with more iodine contrast than tube 2, also stuck to the side of vertebrae when deployed (tube 2 and 3 were not deployed at the same time). Six separate PET/CT imaging sessions were conducted in phase 4, with the following phantom compositions (refer Table 2 ): (a) PET/CT4a imaging of the phantom with saline bag 1 and test tube 1, to simulate imaging a spinal metastasis with liver FDG uptake in the absence of iodine; (b) PET/CT4b imaging of saline bag 2 and tube 1, to simulate imaging a spinal metastasis with a liver with iodine contrast and FDG uptake; (c) PET/CT4c imaging of saline bag 1, tube 1 and tube 2, to simulate imaging a spinal metastasis in proximity to blood vessels with a low contrast uptake and a liver with FDG uptake but no contrast uptake; (d) PET/CT4d imaging of saline bag 2 and tube 1 and tube 2, to simulate imaging a spinal metastasis in proximity to a blood vessel with a low contrast uptake and a liver with FDG uptake and contrast uptake; (e) PET/CT4e imaging of saline bag 1, tube 1 and tube 3, to simulate imaging a spinal metastasis in proximity to a blood vessel with high contrast uptake and a liver with FDG uptake and no contrast uptake; (f) PET/CT4f imaging of saline bag 2, tube 1 and tube 3, to simulate imaging a spinal metastasis in proximity to a blood vessel with high contrast uptake and a liver with FDG uptake and contrast uptake (Fig. 4) .
Image analysis
PET emission images were reconstructed using the 3D row-action maximum-likelihood algorithm (RAMLA) and the attenuation correction was performed using the CT dataset. All co-registered images were reviewed on the workstation in axial, coronal and sagittal planes along with Maximum Intensity Projection (MIP) images. The CT images were reviewed in the soft tissue window setting To measure HUmax for tube 2 and tube 3, the highest pixel values were determined by direct inspection by the operator of the axial images displayed on the CT console. In order to obtain the SUVs as in actual imaging setting, these values were relative to a nominal clinical injected radioactivity for a 70 kg adult. For each of the structures (saline bags 1 and 2, and test tube 1), the SUVs were quantified by carefully drawing a 2-dimensional (2D) region of interest (ROI) on the single slice of the attenuation corrected PET/ CT images; that gave the highest SUVmax and SUVmean values, using an automatic isocontour technique set at the 70% threshold line of the maximum pixel value (Fig. 5c ). These ROIs were segmented by an experienced nuclear medicine technologist. The maximum (SUVmax) and mean (SUVmean) values were recorded. Owing to a very small sample size, thus, the statistical analyses using the non-parametric tests seemed to be more appropriate. The Wilcoxon Signed Rank Test was used to determine the difference in SUVs in phase 3 of the phantom study. For phase 4, the analysis was performed using the non-parametric Friedman Test. P values of less than 0.05 were considered to be statistically significant. The absolute difference in SUVmax and SUVmean values (DSUVmax and DSUVmean) of each structure was also calculated. These statistical analyses were carried out using the SPSS program for Windows version 18.0.
Results
Overall, the range of SUVs for saline bags 1 and 2 generated in this study was 1.5-2.5. In phase 1 of the phantom study, the average HUmax values for saline bag 1 and 2 were about 15 and 105, respectively. Saline bag 2 yielded the average HUmax of 105 after the injection of 15 mL of iodine contrast media (approximately 4.5 mg/ml in concentration). For phase 2, the highest absolute difference in SUVmax value (DSUVmax) between saline bag 1 and 2 in the PET/CT images of phase 2 was ?0.2 (the range for the SUVmax values of both saline bags was 2.1-2.3), whereas the highest DSUVmean was equal to zero; the SUVmean value of 2.0 was detected in all imaging planes. The statistical analysis of results for phase 3 of the phantom study are summarised in Table 3 . The highest DSUVmax from saline bags 1 and 2, and tube 1 were -0.2, -0.2 and ?0.9, respectively (the ranges were found to be 2.1-2.4 for both saline bags, and 9.1-12.5 for tube 1). Furthermore, saline bag 2 and tube 1 demonstrated lesser difference in the highest DSUVmean of about -0.4 and ?0.6 (the SUVmean values were ranging from 1.5 to 1.9 Fig. 4 The set-up for PET/CT imaging of the phase 4 case (f). The black thick arrow shows the position of tube 1 in the vertebral foramen, injected with 1.7 MBq of FDG to simulate a spinal metastasis. The white thick arrow shows the position of tube 3 stuck to the side of dried vertebrae, containing a higher concentration of iodine contrast media (19.0 mg/ml) to simulate the effect of a blood vessel with high contrast uptake. Saline bag 2 (not discernable) is also present to simulate a liver with FDG and iodine contrast uptakes Table 4 . With the separate insertion of other tubes (tubes 2 and 3), the highest DSUVmax for saline bags 1 and 2 were ?0.2 and ?0.1, respectively (the range for the SUVmax values of both saline bags was 2.0-2.3). These two structures exhibited an increase and unchanged in the DSUVmean: ?0.1 for saline bag 1 (it showed the SUVmean value of 1.6) and zero for saline bag 2 (the SUVmean value of 1.6 was detected in all imaging planes). However, the highest absolute difference in tube 1 remained at the same value (?1.5), for both SUVmax (range from 18.4-22.7) and SUVmean (range from 3.6-7.3). Again, all these changes were found to be statistically insignificant (P [ 0.05).
Discussion
Across all phases of this phantom study, the range of SUVs for our saline bags 1 and 2 were found to be within the clinically reported values for the normal liver [20] . The semiquantitative analysis of PET/CT images using the SUVs was reported to provide more precise diagnosis than that of the visual assessment [21] . However, the reproducibility of SUVs mostly depends on the scanning protocols like dose infiltration, time of imaging after FDG injection, type of reconstruction algorithms, type of attenuation maps, size of the region of interest, changes in uptake by organs other than the tumour, and methods of analysis (SUVmax and SUVmean) [22] . Therefore, in the standard clinical practice, the PET/CT findings are still being compared along with other radiological and/or pathological results in establishing the final diagnosis.
In the initial part of our study (phase 2), we investigated the differences in the SUVs of the normal liver caused by the application of iodine contrast media during PET/CT image acquisition. The percentage difference in our SUVmax values (about 10%) is very close to that reported in a previous clinical study by Yau et al. [16] . In the latter part of this study (phases 3 and 4), our works were mainly focused on the simulation of a spinal metastasis. PET/CT imaging features widely in the standard of care for staging, re-staging and assessing the treatment response in many cancer protocols. In addition, some recent clinical studies have recommended that the utilisation of intravenous iodine contrast media during the CT scan of PET/CT imaging can improve the diagnostic accuracy of this integrated imaging modality in detecting lesions [23, 24] . This potential is evidently demonstrated in the oncological imaging [25] , but for the specific case of follow-up for lymphoma, contrast enhancement has been shown to be unnecessary [26] . In PET/CT imaging, the CT data has two main purposes; (a) calculate the attenuation correction factor for the PET emission scans, and (b) provide a precise anatomical localisation of the lesions. The CT scan of PET/CT imaging is commonly conducted without the administration of intravenous or oral contrast media. However, by performing CECT as part of PET/CT imaging, the complete intrinsically co-registered diagnostic morphological and functional data can be obtained in a single imaging session [7] . On the other hand, the use of CECT for attenuation correction of PET imaging has been reported to cause PET/CT image artefacts [10, 27] . The fundamental radiation-physics mechanism for this artefact is well addressed in the literature [4, 5, 28, 29] . To avoid any clinical impact from such artefacts, interpretation using non attenuation-corrected PET images has been suggested [7, 14] . Additionally, it has been reported that there is no pharmacologic interaction between iodine and FDG, as the injections are conducted with an hour interval betweenthem [16] . Therefore, PET/CECT can be considered as a standard of care imaging method, which offers excellent diagnostic accuracy. Based on the results of this study and our recently published patients' data [18] , we also recommend that PET/CECT is sufficient to be used as a routine protocol in the clinical setting.
Our study aimed to quantify the changes in SUVs (SUVmax and SUVmean) with the introduction of iodine contrast media in PET/CT imaging. Based on our analyses, we found the highest percentage difference in SUVmax and SUVmean values were about 10% and 26%, respectively. These values are in agreement with the previous phantom and patient based findings [5, 14, 16, 17] , which have concluded that these changes are found to be not clinically significant. In fact, two previous clinical studies also found even higher differences than ours, the percentage difference in SUVmax due to contrast as high as 27%, and categorised them as clinically insignificant [6, 28] . In addition, our range of absolute difference in SUVmax values were within the range of considered clinically insignificant as reported by Nahmias and Wahl [30] . However, this was not the case for the difference in SUVmean values, as we demonstrated the highest difference of about 1.5. This may be due to the fact that our analyses were only based on single imaging acquisition and if we conducted several scanning sessions, the averaged difference might have been less. Even though our results are sufficient to support the conclusion on clinical significance, there is still room for further optimisation of the measurement technique in future works. In this study, for example, we utilised dried human vertebrae, which has a lower density than encountered in vivo. Hence, we will consider in the future substituting more compact bone like the mid-shaft of the femur, to compensate for the inevitable loss of bone density away from the in vivo environment, and simulate more closely the actual clinical situation of a PET/CECT image of a bone metastasis.
Conclusion
This study has shown that the application of iodine contrast media during PET/CT imaging will not cause any statistically and clinically significant differences in the measurements of SUVmax and SUVmean values for an experimental set-up that mimics a spinal metastasis at the lower abdomen level. Therefore, we conclude that iodine contrast media can be safely used during the CT scan of PET/CT imaging (excluding the patients with contraindications to iodine-based contrast media), without affecting the diagnostic accuracy of this integrated imaging modality. To further establish the clinical advantages of contrast in PET/CT imaging, we propose further investigation using a dual energy CT scan during PET/CT image acquisitions. We would also seek to refine the phantom to a more realistic model of the invasion of bone by a spinal metastasis. In addition, this issue may need to be revisited with the newer generations of PET scanners like Time-of Flight PET (TOF-PET) scanner, which could deliver an improved image quality.
